Additionally, detailed studies on the functional mechanisms of NEAT1, MEG3, and MALAT1 will be essential for elucidating their roles in diagnosing and treating NAFLD, NASH, and fibrosis. Here, MALAT1 is linked to metabolic dysfunction-associated steatohepatitis.